FOCUS COLUMN
By Ramon K. Tabtiang and Steven C. Carlson
This article appears on Page 7
U.S. patent law includes a safe harbor from patent infringement for preparing information for submission to the U.S. Food and Drug Administration. In a recent case, Proveris Scientific Corporation v. Innovasystems, Inc., 2008 WL 2967100, the Court of Appeals of the Federal Circuit interpreted the scope of the safe harbo...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In




